International Journal of Cardiology
Volume 76, Issue 2 , Pages 125-133 , November 2000

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure

  • Mathias Rauchhaus, MD

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • Klinik Innere Medizin III/Kardiologie, Martin-Luther-Universität, Halle, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-345-557-2601; fax: +49-345-557-2072
    • ,
  • Veronika Koloczek

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • ,
  • Hans-Dieter Volk, MD

      Affiliations

    • Institut für Medizinische Immunologie, Charité, Berlin, Germany
    • ,
  • Michael Kemp, FRCPath

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • ,
  • Josef Niebauer, MD PhD

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • ,
  • Darrel P Francis, MRCP

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • ,
  • Andrew J.S Coats, DM

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • ,
  • Stefan D Anker, MD PhD

      Affiliations

    • Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    • Franz-Volhard Klinik at Max-Delbrück Centrum, Charité, (Campus Berlin-Buch), Berlin, Germany

Received 14 January 2000 ,Accepted 28 January 2000.

References 

  1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241
  2. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in “cachectic” patients with severe chronic heart failure. Br Heart J. 1991;66:356–358
  3. Anker SD, Clark AL, Kemp M, et al.  Tumor necrosis factor and steroid metabolism in chronic heart failure. Possible relation to muscle wasting. J Am Coll Cardiol. 1997;30:997–1001
  4. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704–711
  5. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 1997;79:1426–1430
  6. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:1838–1842
  7. Vonhof S, Brost B, Stille-Siegener M, Grumbach IM, Kreuzer H, Figulla HR. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol. 1998;63:237–244
  8. Pedersen TR, Olsson AG, Faergeman O, et al.  Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation. 1998;97:1453–1460
  9. Sacks FM, Pfeffer MA, Moye LA, et al.  Cholesterol and Recurrent Events Trial Investigators   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–1009
  10. Shepherd J, Cobbe SM, Ford I, et al.  West of Scotland Coronary Prevention Study Group   Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307
  11. Kjekshus J, Pedersen TR, Olsson AG, Faergeman O, Pyorala K. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail. 1997;3:249–254
  12. Vredevoe DL, Woo MA, Doering LV, Brecht ML, Hamilton MA, Fonarow GC. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82:323–328
  13. Richartz BM, Radovancevic B, Frazier OH, Vaughn WK, Taegtmeyer H. Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system. Cardiology. 1998;89:184–188
  14. Schlichting E, Aspelin T, Lyberg T. Interactions of endotoxin with human blood cells and serum proteins. Scand J Clin Lab Invest. 1996;56:167–176
  15. Volterrani M, Clark AL, Ludman PF, et al.  Predictors of exercise capacity in chronic heart failure. Eur Heart J. 1994;15:801–809
  16. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJ, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J. 1994;15:1528–1532
  17. Cowie MR, Mosterd A, Wood DA, et al.  The epidemiology of heart failure. Eur Heart J. 1997;18:208–225
  18. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J. 1998;19:761–765
  19. Grundy SM, Balady GJ, Criqui MH, et al.  When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Circulation. 1997;95:1683–1685
  20. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527–532
  21. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526–534
  22. Quezado ZM, Natanson C, Banks SM, et al.  Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock. J Pharmacol Exp Ther. 1995;272:604–611
  23. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990;86:696–702
  24. Memon RA, Grunfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 1993;132:2246–2253
  25. Emancipator K, Csako G, Elin RJ. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun. 1992;60:596–601
  26. Wurfel MM, Wright SD. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J Immunol. 1997;158:3925–3934
  27. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med. 1996;24:584–589
  28. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 1988;37:859–865
  29. Fraunberger P, Pilz G, Cremer P, Werdan K, Walli AK. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock. 1998;10:359–363
  30. Feingold KR, Funk JL, Moser AH, Shigenaga JK, Rapp JH, Grunfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun. 1995;63:2041–2046
  31. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000;12:20–26
  32. Hill GE, Pohorecki R, Whitten CW. Plasma lipid concentrations correlate inversely with CPB-induced interleukin-6 release. Can J Anaesth. 1998;45:509–514
  33. Obialo CI, Okonofua EC, Nzerue MC, Tayade AS, Riley LJ. Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure. Kidney Int. 1999;56:1058–1063

PII: S0167-5273(00)00224-2

International Journal of Cardiology
Volume 76, Issue 2 , Pages 125-133 , November 2000

Article Tools

* Image Usage & Resolution